These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6653640)

  • 21. INHIBITION BY CORTICOSTEROIDS OF RED CELLS LYSIS IN VITRO.
    AGARWAL KN; GARBY L
    Acta Endocrinol (Copenh); 1964; 47():SUPPL 93:3-27. PubMed ID: 14187996
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone.
    Hirano T; Oka K; Takeuchi H; Sakurai E; Matsuno N; Tamaki T; Kozaki M
    Transplantation; 1994 May; 57(9):1341-8. PubMed ID: 8184473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [THE TOPICAL USE OF CORTICOSTEROIDS IN DERMATOLOGY].
    POLANO MK
    Ned Tijdschr Geneeskd; 1965 Jan; 109():180-5. PubMed ID: 14301860
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of in vitro potency of corticosteroids with ability to raise intraocular pressure.
    Cantrill HL; Palmberg PF; Zink HA; Waltman SR; Podos SM; Becker B
    Am J Ophthalmol; 1975 Jun; 79(6):1012-7. PubMed ID: 1173539
    [No Abstract]   [Full Text] [Related]  

  • 25. Macromolecular binding of glucocorticoids in human mammary carcinoma.
    Fazekas AG; MacFarlane JK
    Cancer Res; 1977 Mar; 37(3):640-5. PubMed ID: 837365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical observations on the use of adrenal steroids. Comments on side effects and approaches to avoiding them.
    Kenny FM
    Clin Pediatr (Phila); 1972 Jul; 11(7):395-402. PubMed ID: 5039151
    [No Abstract]   [Full Text] [Related]  

  • 27. [PHARMACOLOGY OF SYNTHETIC CORTICAL STEROIDS OF ANTIINFLAMMATORY ACTION].
    GIJON JR; RODRIGUEZMURCIA C; ALIADIAZ M
    An Real Acad Farm; 1963; 29():361-90. PubMed ID: 14122037
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential glucocorticoid responsiveness of hemodialysis patients' lymphocytes.
    Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Burdick JF
    ASAIO J; 1997; 43(1):31-4. PubMed ID: 9116350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RELATIVE EFFICACY OF DIFFERENT CORTICOSTEROIDS AS HISTAMINE INHIBITORS.
    TRETHEWIE ER
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():166-70. PubMed ID: 14116924
    [No Abstract]   [Full Text] [Related]  

  • 30. Immediate hypersensitivity reactions to corticosteroids.
    Patel A; Bahna SL
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):178-182.e3. PubMed ID: 26211812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroid-induced suppression of in vitro lymphocyte proliferation in four captive rhinoceros species.
    Roth TL; Vance CK
    J Zoo Wildl Med; 2007 Dec; 38(4):518-25. PubMed ID: 18229856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Natural and synthetic glucocorticoids in the racing horse: a review of the literature].
    Klaus AM; Hapke HJ
    Dtsch Tierarztl Wochenschr; 1996 Dec; 103(12):494-500. PubMed ID: 9333538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy.
    Buttgereit F; Brand MD; Burmester GR
    Biochem Pharmacol; 1999 Jul; 58(2):363-8. PubMed ID: 10423179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Side-effects of cortisone derivatives].
    Begemann H; Kaboth W
    Internist (Berl); 1967 Mar; 8(3):85-94. PubMed ID: 4867581
    [No Abstract]   [Full Text] [Related]  

  • 35. Non-genomic rapid inhibition of Na+/H+-exchange 1 and apoptotic immunosuppression in human T cells by glucocorticoids.
    Chang CP; Wang SW; Huang ZL; Wang OY; Huang MI; Lu LM; Tarng DC; Chien CH; Chien EJ
    J Cell Physiol; 2010 Jun; 223(3):679-86. PubMed ID: 20143335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical Pathways of Corticosteroids, Industrial Synthesis from Sapogenins.
    Herráiz I
    Methods Mol Biol; 2017; 1645():15-27. PubMed ID: 28710618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical comparison of the newer anti-inflammatory corticosteroids.
    BOLAND EW
    Ann Rheum Dis; 1962 Jun; 21(2):176-87. PubMed ID: 13870748
    [No Abstract]   [Full Text] [Related]  

  • 38. SIDE-EFFECTS OF LONG-TERM TREATMENT WITH CORTICOSTEROIDS AND CORTICOTROPHIN.
    TREADWELL BL; SEVER ED; SAVAGE O; COPEMAN WS
    Lancet; 1964 May; 1(7343):1121-3. PubMed ID: 14132625
    [No Abstract]   [Full Text] [Related]  

  • 39. [Two new synthetic corticosteroids: the delta-1, 4-pregnandien-17alpha-diol, 21-3, 11, 20-trione (prednisone) and the delta-1, 4-pregnadien-11beta-17alpha, 21,-nyarout-3, 20-dione (prednisolone)].
    CAMPANACCI L
    Farmaco Sci; 1956; 11(1):94-107. PubMed ID: 13317979
    [No Abstract]   [Full Text] [Related]  

  • 40. [GENERAL CORTICOTHERAPY IN DERMATOLOGY].
    BERGOEND H
    Strasb Med; 1963 Oct; 14():789-97. PubMed ID: 14094870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.